Brief: Axcella Therapeutics posts Q2 basic EPS USD -0.05
03/08/2023 12:41
Aug 3 (Reuters) - Axcella Therapeutics Q2 basic EPS USD -0.05. * Q2 income from operations USD -3.543 million * Q2 net income USD -3.413 million * Q2 operating expenses USD 3.543 million
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment